Skip to main content
logo
Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden flag Sweden · Delayed Price · Currency is SEK
273.00
+6.00 (2.25%)
Jun 12, 2026, 5:29 PM CET

Revenue by Segment

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Thoracic
509.32M555.24M384.36M296.35M198.63M
Thoracic Growth
-8.27%44.46%29.70%49.20%-
Services
77.53M87.76M79.14M48.08M6.05M
Services Growth
-11.66%10.89%64.61%694.68%-
Abdominal
225.32M179.42M134.04M70.86M53.71M
Abdominal Growth
25.58%33.86%89.16%31.94%-
Total
812.17M822.42M597.54M415.29M258.39M
Total Growth
-1.25%37.63%43.88%60.73%43.66%

Revenue by Geography

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
USA
427.88M471.54M308.10M224.87M119.64M
USA Growth
-9.26%53.05%37.01%87.96%31.98%
North and South America, Excluding The US
22.26M36.29M25.62M25.49M19.03M
North and South America, Excluding The US Growth
-38.66%41.63%0.53%33.94%8.85%
Asia/Pacific and Oceania
49.20M43.33M42.18M18.81M13.38M
Asia/Pacific and Oceania Growth
13.55%2.74%124.24%40.54%-
Sweden
6.69M3.99M4.22M1.67M2.29M
Sweden Growth
67.68%-5.38%152.57%-27.17%75.57%
EMEA Excluding Sweden
306.13M267.27M---
EMEA Excluding Sweden Growth
14.54%----
The Netherlands
--30.22M25.99M19.42M
The Netherlands Growth
--16.29%33.83%-
Italy
--58.93M21.48M14.78M
Italy Growth
--174.32%45.32%-
EMEA Excluding Sweden,Netherlands and Italy
--128.28M96.99M69.84M
EMEA Excluding Sweden,Netherlands and Italy Growth
--32.27%38.86%-
Total
812.17M822.42M597.54M415.29M258.39M
Total Growth
-1.25%37.63%43.89%60.72%43.66%